Related references
Note: Only part of the references are listed.Comparison of the survival outcome of neoadjuvant therapy followed by radical surgery with that of concomitant chemoradiotherapy in patients with stage IB2-IIIB cervical adenocarcinoma
Tian Tian et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2021)
FGD5-AS1 promotes cisplatin resistance of human lung adenocarcinoma cell via the miR-142-5p/PD-L1 axis
Feng Zhu et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2021)
Role of hsa-miR-105 during the pathogenesis of paclitaxel resistance and its clinical implication in ovarian cancer
Mao Li et al.
ONCOLOGY REPORTS (2021)
LncRNA MST1P2/miR-133b axis affects the chemoresistance of bladder cancer to cisplatin-based therapy via Sirt1/p53 signaling
Jia Chen et al.
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2020)
Locoregional Management After Neoadjuvant Chemotherapy
Monica Morrow et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
The Promising Role of miR-21 as a Cancer Biomarker and Its Importance in RNA-Based Therapeutics
Diana Bautista-Sanchez et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
Lnc-PICSAR contributes to cisplatin resistance by miR-485-5p/REV3L axis in cutaneous squamous cell carcinoma
Dan Wang et al.
OPEN LIFE SCIENCES (2020)
MEG3: an Oncogenic Long Non-coding RNA in Different Cancers
Arwa Al-Rugeebah et al.
PATHOLOGY & ONCOLOGY RESEARCH (2019)
Adenocarcinoma of the uterine cervix: Pathologic features, treatment options, clinical outcome and prognostic variables
Angiolo Gadducci et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2019)
MiR-21-5p enhances the progression and paclitaxel resistance in drug-resistant breast cancer cell lines by targeting PDCD4
L. Tao et al.
NEOPLASMA (2019)
Up-regulation of LncRNA MEG3 inhibits cell migration and invasion and enhances cisplatin chemosensitivity in bladder cancer cells
S. Q. Feng et al.
NEOPLASMA (2018)
Exosomal transfer of tumor-associated macrophage-derived miR-21 confers cisplatin resistance in gastric cancer cells
Peiming Zheng et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
Long non-coding RNA MEG3 contributes to cisplatin-induced apoptosis via inhibition of autophagy in human glioma cells
Binbin Ma et al.
MOLECULAR MEDICINE REPORTS (2017)
Modulation of CASC2/miR-21/PTEN pathway sensitizes cervical cancer to cisplatin
Yeqian Feng et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2017)
MiR-21 promoted proliferation and migration in hepatocellular carcinoma through negative regulation of Navigator-3
Zhipeng Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
The Long Noncoding RNA MEG3 Contributes to Cisplatin Resistance of Human Lung Adenocarcinoma
Jing Liu et al.
PLOS ONE (2015)
Upregulation of the Long Non-Coding RNA HOTAIR Promotes Esophageal Squamous Cell Carcinoma Metastasis and Poor Prognosis
Fang-Jun Chen et al.
MOLECULAR CARCINOGENESIS (2013)
Triptolide modulates the sensitivity of K562/A02 cells to adriamycin by regulating miR-21 expression
Hao Li et al.
PHARMACEUTICAL BIOLOGY (2012)
Long noncoding intronic RNAs are differentially expressed in primary and metastatic pancreatic cancer
Ana C. Tahira et al.
MOLECULAR CANCER (2011)
microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer
C. Braconi et al.
ONCOGENE (2011)
Anti-Tumor Activity of a Novel Compound-CDF Is Mediated by Regulating miR-21, miR-200, and PTEN in Pancreatic Cancer
Bin Bao et al.
PLOS ONE (2011)
Share Paper
